Issue Date | Title | Type | Author(s) |
2023 | BRCT domains: structure, functions, and implications in disease-new therapeutic targets for innovative drug discovery against infections | Revision | Peña-Guerrero, J. (José); Fernández-Rubio, C. (Celia); García-Sosa, A.T. (Alfonso T.); Nguewa, P.A. (Paul Alain) |
2023 | Characterization of Leishmania parasites isolated from naturally infected mammals | Articulo | Burguete-Mikeo, A. (Aroia); Fernández-Rubio, C. (Celia); Peña-Guerrero, J. (José); El-Dirany, R. (Rima); Gainza, L. (Leonardo); Carasa-Buj, B. (Belén); Nguewa-Kamsu, P.A. (Paul Alain) |
2023 | Characterization of potential therapeutic targets in Leishmania infantum | TFG | Casquero-Fernández-de-Ana, C. (Carlos) |
2021 | Discovery and validation of Lmj_04_BRCT domain, a novel therapeutic target: identification of candidate drugs for leishmaniasis | Articulo | Peña-Guerrero, J. (José); Fernández-Rubio, C. (Celia); Burguete-Mikeo, A. (Aroia); El-Dirany, R. (Rima); García-Sosa, A.T. (Alfonso T.); Nguewa, P.A. (Paul Alain) |
2020 | LmjF.22.0810 from Leishmania major Modulates the Th2-Type Immune Response and Is Involved in Leishmaniasis Outcome | Articulo | Vacas, A. (Andrés); Fernández-Rubio, C. (Celia); Larrea, E. (Esther); Peña-Guerrero, J. (José); Nguewa, P.A. (Paul Alain) |
2021 | Potential therapeutic targets shared between leishmaniasis and cancer | Articulo | Rashidi, S. (Sajad); Fernández-Rubio, C. (Celia); Manzano-Román, R. (Raúl); Mansouri, R. (Reza); Shafiei, R. (Reza); Ali-Hassanzadeh, M. (Mohammad); Barazesh, A. (Afshin); Karimazar, M. (Mohammadreza); Hatam, G. (Gholamreza); Nguewa, P.A. (Paul Alain) |
2022 | Repurposing the antibacterial agents peptide 19-4LF and peptide 19-2.5 for treatment of cutaneous leishmaniasis | Articulo | El-Dirany, R. (Rima); Fernández-Rubio, C. (Celia); Peña-Guerrero, J. (José); Moreno-Amatria, E. (Esther); Larrea, E. (Esther); Espuelas, S. (Socorro); Abdel-Sater, F. (Fadi); Brandenburg, K. (Klaus); Martinez-de-Tejada, G. (Guillermo); Nguewa, P.A. (Paul Alain) |
2022 | The BRCT domain from the homologue of the oncogene PES1 in Leishmania major (LmjPES) promotes malignancy and drug resistance in mammalian cells | Articulo | Larrea, E. (Esther); Fernández-Rubio, C. (Celia); Peña-Guerrero, J. (José); Guruceaga, E. (Elizabeth); Nguewa, P.A. (Paul Alain) |
2019 | The novel serine/threonine protein kinase LmjF.22.0810 from leishmania major may be involved in the resistance to drugs such as paromomycin | Articulo | Vacas, A. (Andrés); Fernández-Rubio, C. (Celia); Algarabel, M. (Miriam); Peña-Guerrero, J. (José); Larrea, E. (Esther); Formiga, F.R. (Fabio R.); García-Sosa, A.T. (Alfonso T.); Nguewa, P.A. (Paul Alain) |